SCHEMBL4851372

SCHEMBL4851372

COc1ccc(/C=C/C(=O)c2cc(C)ccc2OCCN(C)C)c(F)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 1/20 0.48
MAPT P10636 3/20 0.45
LMNA P02545 3/20 0.45
GAA P10253 2/20 0.45
ATM Q13315 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
PDE4A P27815 2/20 0.44
PDE4B Q07343 2/20 0.44
PDE4C Q08493 2/20 0.44
PDE4D Q08499 2/20 0.44
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
HPGD P15428 2/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 1/20 0.43
ALOX12 P18054 1/20 0.43
TNFRSF1A P19438 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4855876 1.00 ABCG2 (0.48) ABCG2MAPTLMNAGAAATM
SCHEMBL4852466 0.90 MAPT (0.42) ABCG2MAPTLMNAGAAATM
SCHEMBL4846630 0.90 MAPT (0.42) ABCG2MAPTLMNAGAAATM
SCHEMBL4855883 0.89 HPGD (0.52) ABCG2MAPTLMNAGAAATM
SCHEMBL4854910 0.88 MAPT (0.49) ABCG2MAPTLMNAGAAATM
SCHEMBL4849955 0.88 MAPT (0.49) ABCG2MAPTLMNAGAAATM
SCHEMBL4847380 0.88 KDM4E (0.45) ABCG2MAPTLMNAGAAATM
SCHEMBL4848181 0.88 KDM4E (0.45) ABCG2MAPTLMNAGAAATM
SCHEMBL4854487 0.87 SLC6A9 (0.46) MAPTLMNAGAAATMSMN1; SMN2
SCHEMBL4857394 0.87 SLC6A9 (0.46) MAPTLMNAGAAATMSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed